Medicine and Dentistry
Butylscopolamine
38%
Clinician
25%
Controlled Clinical Trial
25%
Decision Making
25%
Deterioration
8%
Dying
37%
End of Life Care
5%
Health Care
8%
Health Care Provider
25%
Informed Consent
25%
Medical Decision Making
25%
Mucus
8%
Parasympatholytic
12%
Patient Recruitment
8%
Patient Referral
25%
Placebo
100%
Randomized Clinical Trial
25%
Randomized Controlled Trial
21%
Reassurance
25%
Symptomatic Treatment
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cholinergic Receptor Blocking Agent
12%
Controlled Clinical Trial
25%
Deterioration
12%
Dying
41%
Patient Recruitment
12%
Placebo
75%
Randomized Clinical Trial
25%
Randomized Controlled Trial
30%
Scopolamine
12%
Scopolamine Butyl Bromide
42%
Nursing and Health Professions
Deterioration
8%
Dying
33%
Gold Standard
8%
Health Care Personnel
41%
Medical Decision Making
25%
Palliative Therapy
25%
Patient Referral
25%
Placebo
50%
Scopolamine Butyl Bromide
13%
Terminal Care
5%
